Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Italy Fines Apple €98.6 Million Over App Store Dominance 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Dublin, March 18, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/wh78nb/biochips_global) has announced the addition of the "Biochips - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020.
This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others.
The report further analyzes the market by the following Applications: Research, Diagnostics, and Others.
Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 79 companies including many key and niche players such as
- Affymetrix, Inc. (US)
- Agilent Technologies, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Cepheid Inc. (US)
- Fluidigm Corporation (US)
- GE Healthcare Ltd. (UK)
- Hoffman-La-Roche Ltd. (Switzerland)
- Illumina, Inc. (US)
- Ocimum Biosolutions Ltd. (India)
- PerkinElmer, Inc. (US)
- Takara Bio, Inc. (Japan)
- Clontech Laboratories, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. INNOVATIONS IN THE BIOCHIPS INDUSTRY
3. COMPETITION
4. PRODUCT OVERVIEW
5. BIOCHIP AND MICROARRAY CONSTRUCTION
6. APPLICATIONS OF BIOCHIPS
7. PRODUCT INTRODUCTIONS
8. RECENT INDUSTRY ACTIVITY
9. FOCUS ON SELECT GLOBAL PLAYERS
10. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 79 (including Divisions/Subsidiaries 86)
- The United States (45)
- Canada (2)
- Japan (6)
- Europe (22)
- - France (2)
- - Germany (6)
- - The United Kingdom (3)
- - Spain (2)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (10)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/wh78nb/biochips_global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology
